99 related articles for article (PubMed ID: 22657952)
1. Neurocognitive function in long-term treated schizophrenia: a five-year follow-up study.
Ekerholm M; Firus Waltersson S; Fagerberg T; Söderman E; Terenius L; Agartz I; Jönsson EG; Nyman H
Psychiatry Res; 2012 Dec; 200(2-3):144-52. PubMed ID: 22657952
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
5. Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
Ahn YM; Lee KY; Kim CE; Kim JJ; Kang DY; Jun TY; Choi JS; Chung IW; Kim SH; Hwang SS; Kim YS
J Clin Psychopharmacol; 2009 Apr; 29(2):117-23. PubMed ID: 19512972
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
Polgár P
Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
[TBL] [Abstract][Full Text] [Related]
8. Association between attitude toward medication and neurocognitive function in schizophrenia.
Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment of executive function as a core symptom of schizophrenia.
Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
[TBL] [Abstract][Full Text] [Related]
10. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients.
Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P
Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive functioning in a group of offspring genetically at high-risk for schizophrenia in Eastern Turkey.
Ozan E; Deveci E; Oral M; Karahan U; Oral E; Aydin N; Kirpinar I
Brain Res Bull; 2010 May; 82(3-4):218-23. PubMed ID: 20435102
[TBL] [Abstract][Full Text] [Related]
12. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
Tan EJ; Rossell SL
Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
[TBL] [Abstract][Full Text] [Related]
13. The overlap of cognitive impairment in depression and schizophrenia: a comparative study.
Soštarič M; Zalar B
Psychiatr Danub; 2011 Sep; 23(3):251-6. PubMed ID: 21963692
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome.
Cervellione KL; Burdick KE; Cottone JG; Rhinewine JP; Kumra S
J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):867-78. PubMed ID: 17581451
[TBL] [Abstract][Full Text] [Related]
15. Prediction of patient contacts by cognition in schizophrenia.
Ernst Nielsen R; Haugaard C; Olrik Wallenstein Jensen S; Munk-Jørgensen P; Østergaard Christensen T
Aust N Z J Psychiatry; 2013 Jul; 47(7):637-45. PubMed ID: 23574875
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. a case-control study.
Scala S; Lasalvia A; Cristofalo D; Bonetto C; Ruggeri M
Psychiatry Res; 2012 Dec; 200(2-3):137-43. PubMed ID: 22652345
[TBL] [Abstract][Full Text] [Related]
17. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.
Guo X; Zhai J; Wei Q; Twamley EW; Jin H; Fang M; Hu M; Zhao J;
Neurosci Lett; 2011 Oct; 503(2):141-6. PubMed ID: 21888948
[TBL] [Abstract][Full Text] [Related]
19. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
